Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13047
Country/Region: Uganda
Year: 2016
Main Partner: Makerere University
Main Partner Program: School of Medicine
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 48
GEND_GBV Age/Sex: <10 Female 2017 6
GEND_GBV Age/Sex: <10 Male 2017 27
GEND_GBV Age/Sex: <10 Male 2017 2
GEND_GBV Age/Sex: 10-14 Female 2017 131
GEND_GBV Age/Sex: 10-14 Female 2017 14
GEND_GBV Age/Sex: 10-14 Male 2017 27
GEND_GBV Age/Sex: 10-14 Male 2017 2
GEND_GBV Age/Sex: 15-19 Female 2017 21
GEND_GBV Age/Sex: 15-19 Female 2017 234
GEND_GBV Age/Sex: 15-19 Male 2017 2
GEND_GBV Age/Sex: 15-19 male 2017 44
GEND_GBV Age/Sex: 20-24 Female 2017 238
GEND_GBV Age/Sex: 20-24 Female 2017 24
GEND_GBV Age/Sex: 20-24 Male 2017 48
GEND_GBV Age/Sex: 20-24 Male 2017 6
GEND_GBV Age/Sex: 25-49 Female 2017 94
GEND_GBV Age/Sex: 25-49 Female 2017 9
GEND_GBV Age/Sex: 25-49 Male 2017 48
GEND_GBV Age/Sex: 25-49 Male 2017 6
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 8
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 83
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 19
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 208
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 73
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 731
GEND_GBV Number of people receiving post-GBV care 2017 939
GEND_GBV Number of people receiving post-GBV care 2017 92
GEND_GBV Sum of Age/Sex Disaggregates 2017 24
GEND_GBV Sum of Age/Sex Disaggregates 2017 233
HTS_TST Age/sex: <1 2017 83
HTS_TST Age/sex: <1 2017 929
HTS_TST Age/sex: 1-9 2017 269
HTS_TST Age/sex: 1-9 2017 3,054
HTS_TST Age/sex: 10-14 Female 2017 231
HTS_TST Age/sex: 10-14 Female 2017 2,640
HTS_TST Age/sex: 10-14 Male 2017 231
HTS_TST Age/sex: 10-14 Male 2017 2,642
HTS_TST Age/sex: 15-19 Female 2017 527
HTS_TST Age/sex: 15-19 Female 2017 6,667
HTS_TST Age/sex: 15-19 Male 2017 523
HTS_TST Age/sex: 15-19 Male 2017 8,301
HTS_TST Age/sex: 20-24 Female 2017 792
HTS_TST Age/sex: 20-24 Female 2017 10,002
HTS_TST Age/sex: 20-24 Male 2017 783
HTS_TST Age/sex: 20-24 Male 2017 12,459
HTS_TST Age/sex: 25-49 Female 2017 1,214
HTS_TST Age/sex: 25-49 Female 2017 15,333
HTS_TST Age/sex: 25-49 Male 2017 1,200
HTS_TST Age/sex: 25-49 Male 2017 19,101
HTS_TST Age/sex: 50+ Female 2017 106
HTS_TST Age/sex: 50+ Female 2017 1,332
HTS_TST Age/sex: 50+ Male 2017 103
HTS_TST Age/sex: 50+ Male 2017 1,656
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 407
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,633
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 407
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,632
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 2,639
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 33,334
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 2,609
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 41,517
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 6,062
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 84,116
HTS_TST Service Delivery Point (Facility): Index testing 2017 344
HTS_TST Service Delivery Point (Facility): Index testing 2017 5,815
HTS_TST Service Delivery Point (Facility): Inpatient 2017 784
HTS_TST Service Delivery Point (Facility): Inpatient 2017 15,783
HTS_TST Service Delivery Point (Facility): Other PITC 2017 197
HTS_TST Service Delivery Point (Facility): Other PITC 2017 3,328
HTS_TST Service Delivery Point (Facility): Outpatient 2017 528
HTS_TST Service Delivery Point (Facility): Outpatient 2017 10,867
HTS_TST Service Delivery Point (Facility): Pediatric 2017 657
HTS_TST Service Delivery Point (Facility): Pediatric 2017 8,268
HTS_TST Service Delivery Point (Facility): PMTCT 2017 1,923
HTS_TST Service Delivery Point (Facility): PMTCT 2017 17,955
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 67
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 933
HTS_TST Service Delivery Point (Facility): VMMC 2017 1,562
HTS_TST Service Delivery Point (Facility): VMMC 2017 21,167
HTS_TST Sum of Age/Sex disaggregates 2017 5,710
HTS_TST Sum of Age/Sex disaggregates 2017 80,133
HTS_TST Sum of Aggregated Age/Sex <15 2017 814
HTS_TST Sum of Aggregated Age/Sex <15 2017 9,265
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 5,248
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 74,851
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 6,062
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 84,116
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 14
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 147
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 14
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 143
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 28
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 353
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 185
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 43
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 533
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 14
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 282
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 65
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 814
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 19
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 427
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 67
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 3
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 37
HTS_TST_POS Test Result by Age: Positive: <1 2017 2
HTS_TST_POS Test Result by Age: Positive: <1 2017 48
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 16
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 168
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 23
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 256
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 23
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 250
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 142
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,767
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 42
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 931
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 145
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,356
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 1,501
KP_PREV Total estimated number of key population in the catchment area 2017 3,845
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 2,244
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 485
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 1,116
OVC_SERV Age/Sex: 18+ Female 2017 259
OVC_SERV Age/Sex: 18+ Male 2017 215
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 735
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 690
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 1,899
OVC_SERV Sum of Age/Sex disaggregates 2017 474
PMTCT_ART Already on ART at beginning of current pregnancy 2017 97
PMTCT_ART Already on ART at beginning of current pregnancy 2017 940
PMTCT_ART New on ART 2017 69
PMTCT_ART New on ART 2017 676
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,671
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 16,740
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 109
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,067
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 32
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 297
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 2
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 15
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 6
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 57
PMTCT_EID Sum of Infant Age disaggregates 2017 141
PMTCT_EID Sum of Infant Age disaggregates 2017 1,364
PMTCT_STAT By: Known positives at entry 2017 95
PMTCT_STAT By: Known positives at entry 2017 1,029
PMTCT_STAT By: Number of new positives identified 2017 78
PMTCT_STAT By: Number of new positives identified 2017 680
PMTCT_STAT Number of new ANC and L&D clients 2017 1,715
PMTCT_STAT Number of new ANC and L&D clients 2017 17,167
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,671
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 16,740
PMTCT_STAT Sum of Positives Status disaggregates 2017 173
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,709
PP_PREV Aggregated Age/sex: <15 Female 2017 693
PP_PREV Aggregated Age/sex: <15 Male 2017 642
PP_PREV Aggregated Age/sex: 15+ Female 2017 815
PP_PREV Aggregated Age/sex: 15+ Male 2017 816
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 2,960
PP_PREV Total number of people in the target population 2017 55,033
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 16
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 92
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 5
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 33
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 173
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 51
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 280
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 51
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 280
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,137
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 215
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 19
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 310
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 66
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 945
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 130
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,882
TB_SCREENDX Screen Result: Screened Positive for TB 2017 782
TB_SCREENDX Screen Results: Screened Positive for TB 2017 55
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 66
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 60
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 1,693
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 24,529
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 871
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 12,633
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1,081
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 957
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 2,690
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 39,200
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 35
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 128
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 9
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 65
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 234
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 105
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 387
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 106
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 387
TX_CURR Age/Sex: <1 2017 4
TX_CURR Age/Sex: <1 2017 79
TX_CURR Age/Sex: <1-9 2017 489
TX_CURR Age/Sex: 1-9 2017 33
TX_CURR Age/Sex: 10-14 Female 2017 47
TX_CURR Age/Sex: 10-14 Female 2017 790
TX_CURR Age/Sex: 10-14 Male 2017 42
TX_CURR Age/Sex: 10-14 Male 2017 680
TX_CURR Age/Sex: 15-19 Female 2017 83
TX_CURR Age/Sex: 15-19 Female 2017 1,227
TX_CURR Age/Sex: 15-19 Male 2017 26
TX_CURR Age/Sex: 15-19 Male 2017 379
TX_CURR Age/Sex: 20-24 Female 2017 391
TX_CURR Age/Sex: 20-24 Female 2017 5,641
TX_CURR Age/Sex: 20-24 Male 2017 175
TX_CURR Age/Sex: 20-24 Male 2017 2,525
TX_CURR Age/Sex: 25-49 Female 2017 1,136
TX_CURR Age/Sex: 25-49 Female 2017 16,434
TX_CURR Age/Sex: 25-49 Male 2017 626
TX_CURR Age/Sex: 25-49 Male 2017 9,097
TX_CURR Age/Sex: 50+ Female 2017 83
TX_CURR Age/Sex: 50+ Female 2017 1,227
TX_CURR Age/Sex: 50+ Male 2017 44
TX_CURR Age/Sex: 50+ Male 2017 632
TX_CURR Aggregated Age/Sex: <15 Female 2017 66
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,081
TX_CURR Aggregated Age/Sex: <15 Male 2017 60
TX_CURR Aggregated Age/Sex: <15 Male 2017 957
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,693
TX_CURR Aggregated Age/Sex: 15+ Female 2017 24,529
TX_CURR Aggregated Age/Sex: 15+ Male 2017 871
TX_CURR Aggregated Age/Sex: 15+ Male 2017 12,633
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,690
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 39,200
TX_CURR Sum of age/sex disaggregates 2017 1,606
TX_CURR Sum of Age/Sex disaggregations 2017 109
TX_CURR Sum of Aggregated Age/Sex <15 2017 126
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,038
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 2,564
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 37,162
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,690
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 39,200
TX_NEW Aggregated Grouping by Age: <1 2017 2
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 22
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 182
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 19
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 154
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 288
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,816
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 150
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,448
TX_NEW By Age/Sex: <1 2017 11
TX_NEW By Age/Sex: 1-9 2017 9
TX_NEW By Age/Sex: 1-9 2017 79
TX_NEW By Age/Sex: 10-14 Female 2017 17
TX_NEW By Age/Sex: 10-14 Female 2017 137
TX_NEW By Age/Sex: 10-14 Male 2017 13
TX_NEW By Age/Sex: 10-14 Male 2017 109
TX_NEW By Age/Sex: 15-19 Female 2017 14
TX_NEW By Age/Sex: 15-19 Female 2017 141
TX_NEW By Age/Sex: 15-19 Male 2017 4
TX_NEW By Age/Sex: 15-19 Male 2017 40
TX_NEW By Age/Sex: 20-24 Female 2017 67
TX_NEW By Age/Sex: 20-24 Female 2017 650
TX_NEW By Age/Sex: 20-24 Male 2017 31
TX_NEW By Age/Sex: 20-24 Male 2017 289
TX_NEW By Age/Sex: 25-49 Female 2017 193
TX_NEW By Age/Sex: 25-49 Female 2017 1,884
TX_NEW By Age/Sex: 25-49 Male 2017 107
TX_NEW By Age/Sex: 25-49 Male 2017 1,040
TX_NEW By Age/Sex: 50+ Female 2017 14
TX_NEW By Age/Sex: 50+ Female 2017 141
TX_NEW By Age/Sex: 50+ Male 2017 8
TX_NEW By Age/Sex: 50+ Male 2017 79
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 479
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,600
TX_NEW Sum of Age/Sex disaggregates 2017 468
TX_NEW Sum of Age/Sex disaggregates 2017 4,510
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 479
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,600
VMMC_CIRC By Age: 10-14 2017 8,865
VMMC_CIRC By Age: 15-19 2017 6,594
VMMC_CIRC By Age: 20-24 2017 3,184
VMMC_CIRC By Age: 25-29 2017 1,817
VMMC_CIRC By Age: 30-49 2017 1,817
VMMC_CIRC By Age: 50+ 2017 452
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 22,729
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 22,729
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 22,729
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 19,095
Mechanism Allocation by Budget Code for Selected Year
6.1%7.6%9.1%10.6%12.1%13.6%15.2%16.7%0-10123456789101112HBHCHKIDHVTBPDCSHLABHVSICIRCHVCTHVOPMTCTHTXSPDTX
Planned Funding by Program Area over Known Duration of Mechanism
201120122013201420152016$0$1,000,000$2,000,000$3,000,000$4,000,000$5,000,000$6,000,000$7,000,000$8,000,000$9,000,000$10,000,000$11,000,000$12,000,000$13,000,000CareGovernance and SystemsPreventionTestingTreatment